Cite
Jachimowicz RD, Klapper W, Glehr G, et al. Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia. 2021;35(12):3589-3593doi: 10.1038/s41375-021-01314-1.
Jachimowicz, R. D., Klapper, W., Glehr, G., Müller, H., Haverkamp, H., Thorns, C., Hansmann, M. L., Möller, P., Stein, H., Rehberg, T., von Tresckow, B., Reinhardt, H. C., Borchmann, P., Chan, F. C., Spang, R., Scott, D. W., Engert, A., Steidl, C., Altenbuchinger, M., & Rosenwald, A. (2021). Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia, 35(12), 3589-3593. https://doi.org/10.1038/s41375-021-01314-1
Jachimowicz, Ron D, et al. "Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP." Leukemia vol. 35,12 (2021): 3589-3593. doi: https://doi.org/10.1038/s41375-021-01314-1
Jachimowicz RD, Klapper W, Glehr G, Müller H, Haverkamp H, Thorns C, Hansmann ML, Möller P, Stein H, Rehberg T, von Tresckow B, Reinhardt HC, Borchmann P, Chan FC, Spang R, Scott DW, Engert A, Steidl C, Altenbuchinger M, Rosenwald A. Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia. 2021 Dec;35(12):3589-3593. doi: 10.1038/s41375-021-01314-1. Epub 2021 Jun 10. PMID: 34112956.
Copy
Download .nbib